CD200 and head and neck squamous cell carcinoma: According to Shin et al., CD200 expression in head and neck squamous cell carcinoma (HSNCC) tumors was reported to upregulate the expression of immune-related genes, including macrophage colony-stimulating factor (M-CSF) [23].